Global Androgen Deprivation Therapy (ADT) Market Research Report 2024

Androgen Deprivation Therapy (ADT) Market

Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.

North American market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Androgen Deprivation Therapy (ADT) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Androgen Deprivation Therapy (ADT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Deprivation Therapy (ADT).

Report Scope

The Androgen Deprivation Therapy (ADT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgen Deprivation Therapy (ADT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Androgen Deprivation Therapy (ADT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Pfizer

Astellas Pharma

Johnson & Johnson

Novartis International

Merck

Veru

Sanofi

GlaxoSmithKline

Bayer

Orion

AstraZeneca

Medicine

Surgery

Other

Hospital

Clinic

Other

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Androgen Deprivation Therapy (ADT) Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Medicine

1.2.3 Surgery

1.2.4 Other

1.3 Market by Application

1.3.1 Global Androgen Deprivation Therapy (ADT) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2019-2030)

2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Region

2.2.1 Global Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2019-2024)

2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030)

2.3 Androgen Deprivation Therapy (ADT) Market Dynamics

2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends

2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers

2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges

2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints

3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue

3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2019-2024)

3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2019-2024)

3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue

3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio

3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2023

3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served

3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service

3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2019-2024)

4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030)

5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2019-2024)

5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030)

6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)

6.2 North America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)

6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2019-2030)

7.2 Europe Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)

7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2019-2030)

8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024)

8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)

9.2 Latin America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)

9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2019-2030)

10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)

10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction

11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Detail

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction

11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.2.5 Astellas Pharma Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Detail

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction

11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.3.5 Johnson & Johnson Recent Development

11.4 Novartis International

11.4.1 Novartis International Company Detail

11.4.2 Novartis International Business Overview

11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction

11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.4.5 Novartis International Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction

11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Veru

11.6.1 Veru Company Detail

11.6.2 Veru Business Overview

11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction

11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.6.5 Veru Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction

11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Detail

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction

11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.8.5 GlaxoSmithKline Recent Development

11.9 Bayer

11.9.1 Bayer Company Detail

11.9.2 Bayer Business Overview

11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction

11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.9.5 Bayer Recent Development

11.10 Orion

11.10.1 Orion Company Detail

11.10.2 Orion Business Overview

11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction

11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.10.5 Orion Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Detail

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction

11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)

11.11.5 AstraZeneca Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Medicine

    Table 3. Key Players of Surgery

    Table 4. Key Players of Other

    Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2024)

    Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2025-2030)

    Table 11. Androgen Deprivation Therapy (ADT) Market Trends

    Table 12. Androgen Deprivation Therapy (ADT) Market Drivers

    Table 13. Androgen Deprivation Therapy (ADT) Market Challenges

    Table 14. Androgen Deprivation Therapy (ADT) Market Restraints

    Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2019-2024)

    Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)

    Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service

    Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2019-2024)

    Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2025-2030)

    Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2019-2024)

    Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2025-2030)

    Table 32. North America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Pfizer Company Detail

    Table 48. Pfizer Business Overview

    Table 49. Pfizer Androgen Deprivation Therapy (ADT) Product

    Table 50. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 51. Pfizer Recent Development

    Table 52. Astellas Pharma Company Detail

    Table 53. Astellas Pharma Business Overview

    Table 54. Astellas Pharma Androgen Deprivation Therapy (ADT) Product

    Table 55. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 56. Astellas Pharma Recent Development

    Table 57. Johnson & Johnson Company Detail

    Table 58. Johnson & Johnson Business Overview

    Table 59. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product

    Table 60. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 61. Johnson & Johnson Recent Development

    Table 62. Novartis International Company Detail

    Table 63. Novartis International Business Overview

    Table 64. Novartis International Androgen Deprivation Therapy (ADT) Product

    Table 65. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 66. Novartis International Recent Development

    Table 67. Merck Company Detail

    Table 68. Merck Business Overview

    Table 69. Merck Androgen Deprivation Therapy (ADT) Product

    Table 70. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 71. Merck Recent Development

    Table 72. Veru Company Detail

    Table 73. Veru Business Overview

    Table 74. Veru Androgen Deprivation Therapy (ADT) Product

    Table 75. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 76. Veru Recent Development

    Table 77. Sanofi Company Detail

    Table 78. Sanofi Business Overview

    Table 79. Sanofi Androgen Deprivation Therapy (ADT) Product

    Table 80. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 81. Sanofi Recent Development

    Table 82. GlaxoSmithKline Company Detail

    Table 83. GlaxoSmithKline Business Overview

    Table 84. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product

    Table 85. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 86. GlaxoSmithKline Recent Development

    Table 87. Bayer Company Detail

    Table 88. Bayer Business Overview

    Table 89. Bayer Androgen Deprivation Therapy (ADT) Product

    Table 90. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 91. Bayer Recent Development

    Table 92. Orion Company Detail

    Table 93. Orion Business Overview

    Table 94. Orion Androgen Deprivation Therapy (ADT) Product

    Table 95. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 96. Orion Recent Development

    Table 97. AstraZeneca Company Detail

    Table 98. AstraZeneca Business Overview

    Table 99. AstraZeneca Androgen Deprivation Therapy (ADT) Product

    Table 100. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)

    Table 101. AstraZeneca Recent Development

    Table 102. Research Programs/Design for This Report

    Table 103. Key Data Information from Secondary Sources

    Table 104. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Androgen Deprivation Therapy (ADT) Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2023 VS 2030

    Figure 3. Medicine Features

    Figure 4. Surgery Features

    Figure 5. Other Features

    Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2023 VS 2030

    Figure 8. Hospital Case Studies

    Figure 9. Clinic Case Studies

    Figure 10. Other Case Studies

    Figure 11. Androgen Deprivation Therapy (ADT) Report Years Considered

    Figure 12. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2023 VS 2030

    Figure 15. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2023

    Figure 16. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2023

    Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)

    Figure 20. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)

    Figure 24. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2030)

    Figure 32. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)

    Figure 40. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)

    Figure 44. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 47. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 48. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 49. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 50. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 51. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 52. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 53. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 54. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 55. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 56. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed